Stocks and Investing Stocks and Investing
Thu, November 3, 2022
[ 12:00 AM ] - WOPRAI
David Saxon Maintained (STAA) at Strong Buy with Decreased Target to $83 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Ryan Zimmerman Maintained (STAA) at Strong Buy with Decreased Target to $80 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Gil Blum Maintained (SRPT) at Strong Buy with Decreased Target to $158 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Judah Frommer Maintained (SRPT) at Hold with Increased Target to $101 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (SRPT) at Buy with Decreased Target to $190 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Salveen Richter Maintained (SRPT) at Strong Buy with Increased Target to $171 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Tazeen Ahmad Maintained (SRPT) at Strong Buy with Decreased Target to $129 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Kelly Bania Maintained (SPTN) at Hold and Held Target at $31 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Joseph Altobello Maintained (SMG) at Strong Buy with Decreased Target to $56 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Zekauskas Maintained (SMG) at Hold with Decreased Target to $45 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Omar Nokta Maintained (TNK) at Strong Buy with Increased Target to $40 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Stephen Laws Maintained (TRTX) at Strong Buy with Decreased Target to $11 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Richard Shane Maintained (TRTX) at Hold with Decreased Target to $8 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Clarke Jeffries Maintained (TRMB) at Hold with Decreased Target to $65 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (TRMB) at Hold with Decreased Target to $63 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Tami Zakaria Maintained (TRMB) at Hold with Decreased Target to $58 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Marcelo Santos Maintained (TV) at Buy with Decreased Target to $8.5 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
James Ricchiuti Maintained (TTMI) at Strong Buy with Decreased Target to $18 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Andrew Kaplowitz Maintained (TT) at Strong Buy with Increased Target to $185 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
John Walsh Maintained (TT) at Buy with Increased Target to $187 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (TT) at Buy with Increased Target to $183 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Stephen Tusa Maintained (TT) at Sell with Increased Target to $126 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Deane Dray Maintained (TT) at Hold with Increased Target to $162 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Joe Ritchie Maintained (TT) at Hold with Increased Target to $168 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (TT) at Buy with Increased Target to $170 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Brett Linzey Maintained (TT) at Hold with Increased Target to $155 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (TT) at Hold with Increased Target to $170 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Puneet Souda Maintained (VCYT) at Buy with Increased Target to $35 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (VCYT) at Strong Buy with Increased Target to $33 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Andrew Fein Maintained (UTHR) at Strong Buy with Increased Target to $300 on, Nov 3rd, 2022

Andrew Fein Maintained (UTHR) at Strong Buy with Increased Target to $300 on, Nov 3rd, 2022


Published on 2024-10-27 23:53:31 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Increased Target from $255 to $300 on, Nov 3rd, 2022.

Andrew, nor any peers, have made any analyst calls on UTHR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources